Statement emphasizes the pharmacist's role in educating patients, including the importance of disposing of unused medication Read More »

Quanta Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced that it has partnered with PharmaLynk. Read More »

Accredo, a specialty pharmacy that serves people who take medications for complex and rare conditions, today opened a new, full-service pharmacy for residents of Hawaii who require additional clinical and administrative support for their complex treatments and medications. Read More »

More likely to seek expanded responsibilities Read More »

Leading specialty and home delivery pharmacy expands offering of hard-to-find medicines to meet needs of patients with rare conditions Read More »

PharmScript, a leading pharmacy provider to long-term care and post-acute care facilities, announced the opening of a new pharmacy in Abilene, Texas. Read More »

Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Veterinary ophthalmic drug products and lots, within expiry, identified below. This recall is only for the specific lots listed. No other lots are being recalled. Read More »

Study Evaluated Efficacy and Safety of ABP 798 Compared to Rituxan in Patients With Non-Hodgkin's Lymphoma Read More »

Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation Read More »

Former Publix Super Markets Pharmacy Executive joins company as it expands its 3D-printed product portfolio Read More »

Collaboration combines strengths to develop and commercialize life-saving antifungal treatment and prophylaxis, an area of high unmet medical need Read More »

CTP-543 Achieved its Primary Endpoint in the 8 mg and 12 mg Twice-Daily Dosing Cohorts Read More »

Grane Rx--the leading provider of senior care pharmacy solutions--proudly celebrates 25 years in business this month. Grane Rx opened its doors in 1994 to serve Pennsylvanians and today serves more than 11,500 residents and participants across 70+ facilities nationwide. Read More »

New Board Members Also Announced, Including Representatives from AstraZeneca, UCB, and US Bioservices2019-2020 NASP President-Elect Announced Read More »

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene Therapy, being held September 23-24, 2019 in New York City. Read More »

Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potential treatment of Stage IIb-IV melanoma. Read More »

TWILIGHT Study Fails to Answer Key Scientific Question Regarding Most Efficacious Treatment Post-PCI Read More »

Acquisition is expected to realize over $10M in annual synergies Read More »

PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). Read More »

MedicaSafe will combine the generic version of Suboxone® (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence Read More »